This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Sources searched to identify primary studies
A broad range of data sources (both published and unpublished) was considered. These included a small randomised controlled trial, population-based registries, and other observational studies. These data were supplemented by expert opinion where other data sources were unavailable.
Methods used to judge relevance and validity, and for extracting data
Data for prevalence at screen and birth, test performance and risk of cardiovascular collapse were derived from a systematic review and from a population-based register of CHDs in the Northern Region of England. Searches for the systematic review were conducted using MEDLINE (1966 onward), EMBASE (1980 onward) and CINAHL (1982 onward)' no other details of the review were given. Where data were not available, subjective probabilities were elicited from the consensus reached by two or three paediatric cardiologists and then translated to probability distributions.
Measure of benefits used in the economic analysis
The measure of benefit used was timely diagnosis per 100,000 births. This was defined as a diagnosis made preoperatively before collapse or death occurred. Timely diagnosis and diagnosis of clinically significant CHD was considered a secondary outcome.
Direct costs
The health service costs considered were those of screening and diagnostic tests, management of collapsed infants, staff, equipment, consumables and overheads. These costs were adjusted to 2000/01 prices but were not discounted as the model involved a 1-year time horizon. Sources included primary observations at hospitals, department of health statistics, a study of the literature and expert opinion. The unit costs were estimated from national statistics. The marginal costs were provided.
Statistical analysis of costs
No statistical analysis of the costs was performed.
Indirect Costs
No productivity costs were included.
Currency
UK pounds sterling (). The conversion rate (13 September 2006) was 1 = US $1.872 = EUR 1.478.
Sensitivity analysis
The robustness of the base-case analysis was tested through a series of one-way sensitivity analyses. Parameter uncertainty was evaluated through a probabilistic sensitivity analysis, and probability distributions to input parameters were defined. The results were displayed using cost-effectiveness acceptability curves. In addition, a value-ofinformation analysis was used to assess the value of perfect information, and the partial expected value of information for groups of model input parameters.
Estimated benefits used in the economic analysis
Timely diagnosis per 100,000 births was 34.0 for clinical diagnosis, 70.6 for pulse oximetry and 71.3 for screening echocardiography.
